17 completed. 17 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 17 | Completed 17 |
Follow Measles: new trials by email Literature Review of Measles trials Research Report on Measles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles | Phase 4 | Completed | Liaoning Chengda Biotechnology CO., LTD | 408 | 2024-03-02 | 2025-08-28 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine Mumps vaccine, measles, mumps and rubella combined vaccine, live - Mumps | Phase 4 | Completed | Sinovac (Dalian) Vaccine Technology Co., Ltd. | 920 | 2020-11-18 | 2021-08-18 |
| Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Measles-rubella (MR) vaccine at 6 months of age, Measles-rubella (MR) vaccine at 9 months of age - Measles, Rubella | Phase 4 | Completed | Centers for Disease Control and Prevention | 637 | 2017-03-09 | 2025-07-16 |
| Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Live attenuated SA 14-14-2 Japanese Encephalitis vaccine, Measles, mumps, rubella vaccine - Encephalitis, Japanese, Measles | Phase 4 | Completed | PATH | 628 | 2016-10-13 | 2020-10-14 |
| Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine Measles, mumps and rubella Combined Vaccine, Live - Measles, Mumps | Phase 4 | Completed | Centers for Disease Control and Prevention, China | 873 | 2016-03-01 | 2017-05-19 |
| Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines Measles-Rubella combined vaccine(MR), Japanese Encephalitis alive vaccine(JE) - Measles, Rubella | Phase 4 | Completed | Centers for Disease Control and Prevention, China | 1043 | 2015-08-01 | 2016-08-01 |
| Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR Combined measles-mumps-rubella (MMR) vaccine - PRIORIX® - Measles, Rubella | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 14 | 2015-02-04 | 2026-03-30 |
| Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations MMR Vaccine - Measles, Mumps | Phase 4 | Completed | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 240 | 2012-10-01 | 2016-07-11 |
| Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) VAQTA®, ProQuad - Hepatitis A, Measles | Phase 4 | Completed | Merck Sharp & Dohme LLC | 1800 | 2007-03-26 | 2019-02-04 |
| Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella, Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine - Measles, Mumps | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 470 | 2006-09-01 | 2014-01-22 |
| Immunology of Non-specific Effects of Vaccine Measles vaccine - Measles, Diphtheria | Phase 4 | Completed | Bandim Health Project | 400 | 2006-01-01 | 2011-09-22 |
| Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Measles, Mumps, Rubella and Chickenpox (live vaccine) - Mumps, Rubella | Phase 4 | Completed | GlaxoSmithKline | 1439 | 2005-05-01 | 2016-09-21 |
| Safety Study of a Refrigerator-stable Formulation of VARIVAX® VARIVAX®, M-M-RTM II - Varicella, Measles | Phase 4 | Completed | Merck Sharp & Dohme LLC | 500 | 2004-12-01 | 2017-03-14 |
| Early Two-dose Measles Vaccination Trial Measles vaccine - Measles | Phase 4 | Completed | Bandim Health Project | 5879 | 2003-07-01 | 2012-03-06 |
| Long-term Follow-up of Measles Antibodies Measles vaccine - Measles | Phase 4 | Completed | Bandim Health Project | 1960 | 2002-03-01 | 2011-09-22 |
| Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. MMR vaccine (Priorix) - Rubella, Mumps | Phase 4 | Completed | GlaxoSmithKline | 150 | 2000-11-01 | 2016-09-20 |
| Non-Specific Effects of Standard Titre Measles Vaccination Measles and inactivated polio vaccine - Measles | Phase 4 | Completed | Bandim Health Project | 7800 | 1995-03-01 | 2008-02-26 |
Rubella (12) · Mumps (11) · Chickenpox (3) · Encephalitis, Japanese (3) · Infant Death (3) · Hepatitis A (2) · Diphtheria (1) · Rubella Syndrome, Congenital (1) · Tetanus (1) · Whooping Cough (1)
Infections (17) · Mononegavirales Infections (17) · Morbillivirus Infections (17) · Paramyxoviridae Infections (17) · RNA Virus Infections (17) · Virus Diseases (17) · Rubivirus Infections (12) · Togaviridae Infections (12) · Mouth Diseases (11) · Parotid Diseases (11) · Parotitis (11) · Rubulavirus Infections (11) · Salivary Gland Diseases (11) · Stomatognathic Diseases (11) · Arbovirus Infections (3)
Measles-Mumps-Rubella Vaccine (5) · Measles Vaccine (3) · Aging (1) · Chickenpox Vaccine (1) · Hepatitis A Vaccines (1) · Long-Term Synaptic Depression (1) · Mumps Vaccine (1) · Poliovirus Vaccine, Inactivated (1) · Vaccines, Attenuated (1) · measles, mumps, rubella, varicella vaccine (1)
Bandim Health Project (4) · Centers for Disease Control and Prevention, China (2) · GlaxoSmithKline (2) · Merck Sharp & Dohme LLC (2) · Assistance Publique - Hôpitaux de Paris (1) · Centers for Disease Control and Prevention (1) · Liaoning Chengda Biotechnology CO., LTD (1) · PATH (1) · Sanofi Pasteur, a Sanofi Company (1) · Sinovac (Dalian) Vaccine Technology Co., Ltd. (1) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)
China (4) · Guinea-Bissau (4) · France (2) · Bangladesh (1) · Brazil (1) · Finland (1) · Germany (1) · Greece (1) · Italy (1) · Philippines (1) · Poland (1) · Turkey (Türkiye) (1)
Huanyu Wang (1) · Huaqing Wang, MD, PhD (1) · Jiang Wu (1) · K. Zaman, MD (1) · Lirong Huang, Bachelor (1) · Maria Rosario Capeding, MD (1) · May-Lill Garly, PHD, DTM&H (1) · Odile Launay, MD, PhD (1)
PMID 10342702, PMID 11228365, PMID 11672911, PMID 12443658, PMID 12798618, PMID 14506371, PMID 15082642, PMID 15626943, PMID 15659474, PMID 18653640, PMID 19305145, PMID 21118875, PMID 23994379, PMID 24436454, PMID 24688075, PMID 24829213, PMID 24835247, PMID 25131735, PMID 27912735, PMID 28992261, PMID 30833160, PMID 40179934
2014 (1)